Acorda Therapeutics, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q1 2010 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Acorda Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q1 2010 to Q1 2024.
  • Acorda Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending March 31, 2024 was 1.24M shares, unchanged year-over-year.
  • Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 1.24M shares, a 22.8% increase from 2022.
  • Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 1.01M shares, a 90.5% decline from 2021.
  • Acorda Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2021 was 10.6M shares, a 31.4% increase from 2020.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 1.24M 0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-14
Q4 2023 1.24M +231K +22.8% Oct 1, 2023 Dec 31, 2023 10-K 2024-04-01
Q3 2023 1.24M +2K +0.16% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-14
Q2 2023 1.24M +378K +43.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 1.24M -12M -90.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-14
Q4 2022 1.01M -9.61M -90.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-04-01
Q3 2022 1.24M -9.89M -88.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 864K -9.13M -91.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 13.3M +3.78M +39.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-11
Q4 2021 10.6M +2.54M +31.4% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 11.1M +3.17M +39.8% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-14
Q2 2021 9.99M +2.03M +25.5% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 9.47M +1.51M +19% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-13
Q4 2020 8.08M +157K +1.98% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-18
Q3 2020 7.96M -39.6M -83.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-12
Q2 2020 7.96M -39.5M -83.2% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 7.96M -39.5M -83.2% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q4 2019 7.93M -39.1M -83.1% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-16
Q3 2019 47.5M +327K +0.69% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 47.5M +687K +1.47% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 47.5M +943K +2.03% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 47M +1.01M +2.2% Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 47.2M +1.18M +2.57% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-07
Q2 2018 46.8M +856K +1.86% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-07
Q1 2018 46.5M +721K +1.57% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 46M +740K +1.64% Oct 1, 2017 Dec 31, 2017 10-K 2020-02-28
Q3 2017 46M +624K +1.38% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-06
Q2 2017 45.9M +605K +1.33% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-08
Q1 2017 45.8M +993K +2.22% Jan 1, 2017 Mar 31, 2017 10-Q 2017-05-09
Q4 2016 45.3M +3.03M +7.17% Oct 1, 2016 Dec 31, 2016 10-K 2019-02-27
Q3 2016 45.4M +3.2M +7.6% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-07
Q2 2016 45.3M +3.25M +7.73% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-08
Q1 2016 44.8M +2.78M +6.62% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-09
Q4 2015 42.2M +1.08M +2.63% Oct 1, 2015 Dec 31, 2015 10-K/A 2018-03-09
Q3 2015 42.2M +1.08M +2.63% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-07
Q2 2015 42.1M +1.05M +2.57% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-04
Q1 2015 42M +1.1M +2.68% Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-06
Q4 2014 41.2M +942K +2.34% Oct 1, 2014 Dec 31, 2014 10-K 2017-02-27
Q3 2014 41.1M +779K +1.93% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 41M +1.07M +2.68% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-07
Q1 2014 40.9M +1.1M +2.77% Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-08
Q4 2013 40.2M +749K +1.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 40.3M +852K +2.16% Jul 1, 2013 Sep 30, 2013 10-Q 2014-11-07
Q2 2013 40M +527K +1.34% Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-07
Q1 2013 39.8M +492K +1.25% Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-09
Q4 2012 39.5M +459K +1.18% Oct 1, 2012 Dec 31, 2012 10-K 2015-02-27
Q3 2012 39.5M +363K +0.93% Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-07
Q2 2012 39.4M +496K +1.27% Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-08
Q1 2012 39.3M +559K +1.44% Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-10
Q4 2011 39M +645K +1.68% Oct 1, 2011 Dec 31, 2011 10-K 2014-03-03
Q3 2011 39.1M +650K +1.69% Jul 1, 2011 Sep 30, 2011 10-Q 2012-11-08
Q2 2011 38.9M +631K +1.65% Apr 1, 2011 Jun 30, 2011 10-Q 2012-08-08
Q1 2011 38.8M +760K +2% Jan 1, 2011 Mar 31, 2011 10-Q 2012-05-09
Q4 2010 38.4M Oct 1, 2010 Dec 31, 2010 10-K 2013-02-28
Q3 2010 38.5M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-07
Q2 2010 38.3M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-08
Q1 2010 38M Jan 1, 2010 Mar 31, 2010 10-Q 2011-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.